Pembrolizumab in Early Triple-Negative Breast Cancer. Reply

  1. Schmid, P.
  2. Cortes, J.
  3. Dent, R.
Journal:
The New England journal of medicine

ISSN: 1533-4406

Year of publication: 2022

Volume: 386

Issue: 18

Pages: 1771-1772

Type: Letter

DOI: 10.1056/NEJMC2203316 GOOGLE SCHOLAR